Oregon's Approach To Demonstrating The Value Of A Modern Public Health System Through Accountability Metrics.


Journal

Health affairs (Project Hope)
ISSN: 1544-5208
Titre abrégé: Health Aff (Millwood)
Pays: United States
ID NLM: 8303128

Informations de publication

Date de publication:
Jun 2024
Historique:
medline: 3 6 2024
pubmed: 3 6 2024
entrez: 3 6 2024
Statut: ppublish

Résumé

Oregon's public health system uses accountability metrics to improve health, eliminate inequities, and practice stewardship. First enacted into law during the 2015 legislative session, with additions and clarifications made in the 2017 session, these metrics promote collective action across sectors, bring attention to the root causes of health inequities, and hold public health authorities accountable for performance improvement as they carry out core public health functions. This article describes the development of Oregon's accountability metrics and implications for future practice. In 2023, Oregon's public health leaders adopted a new set of health outcome indicators and process measures for communicable disease control and environmental health, with performance tied to financial incentives. Oregon's process is a model for other states developing an accountability framework in their pursuit of public health transformation. Oregon's work contributes to legislative and other policy decisions for measuring the success of approaches to eliminating health inequities and for applying performance-based incentives within the public health system.

Identifiants

pubmed: 38830165
doi: 10.1377/hlthaff.2024.00012
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

864-872

Auteurs

Kusuma Madamala (K)

Kusuma Madamala, Oregon Health Authority, Portland, Oregon.

Sara Beaudrault (S)

Sara Beaudrault (Sara.BEAUDRAULT@oha.oregon.gov), Oregon Health Authority.

Timothy Menza (T)

Timothy Menza, University of Washington, Seattle, Washington.

Cara Biddlecom (C)

Cara Biddlecom, Oregon Health Authority.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH